Stockreport

Psyence BioMed Announces Exercise of Put Option by PsyLabs and Strategic Equity Investment

Psyence Biomedical Ltd. - Common Shares  (PBM) 
PDF NEW YORK, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-der [Read more]